Immunic (IMUX) Gains from Investment Securities (2013 - 2024)
Immunic's (IMUX) quarterly Gains from Investment Securities came in at $448000.0 in Q4 2024, down 95.67% quarter-over-quarter from $10.3 million in Q3 2023.
Immunic (IMUX) Gains from Investment Securities (2013 - 2024) Analysis & Trends
Immunic has disclosed Gains from Investment Securities across 8 years of filings, most recently posting $448000.0 for Q4 2024.
- Gains from Investment Securities for Q4 2024 came in at $448000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $448000.0 (down 17.65% YoY), and the FY2024 annual result was $448000.0, down 17.65% from the prior year.
- Gains from Investment Securities came in at $448000.0 for Q4 2024 at Immunic, down from $10.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $10.3 million in Q3 2023 to a low of -$5.4 million in Q1 2023.
- The 4-year median for Gains from Investment Securities is $441500.0 (2021), against an average of $400166.7.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 448,000.00 |
| Dec 31, 2024 | 448,000.00 |
| Sep 30, 2023 | 10.34 Mn |
| Sep 30, 2023 | 10.34 Mn |
| Jun 30, 2023 | -4.36 Mn |
| Jun 30, 2023 | -4.36 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Dec 31, 2022 | 974,000.00 |
| Dec 31, 2022 | 974,000.00 |
| Mar 31, 2021 | 435,000.00 |
| Mar 31, 2021 | 435,000.00 |
| Dec 31, 2019 | -303,000.00 |
| Dec 31, 2019 | -303,000.00 |
| Sep 30, 2019 | 303,000.00 |
| Sep 30, 2019 | 303,000.00 |
| Jun 30, 2019 | -106,000.00 |
| Jun 30, 2019 | -106,000.00 |
| Mar 31, 2019 | 132,000.00 |
| Mar 31, 2019 | 132,000.00 |